secwatch.observer — SEC 8-K summary
======================================

Issuer:     TFF Pharmaceuticals, Inc. (—)
CIK:        0001733413
Form:       8-K
Filed at:   2024-03-22T23:59:59+00:00
Accession:  0001213900-24-025167
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 1.01, 3.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

TFF Pharmaceuticals raises ~$1.2M in registered direct offering with warrants at $8.00/share
--------------------------------------------------------------------------------

- Sold 147,500 shares at $8.00 in registered direct offering; gross proceeds ~$1.2M.
- Concurrent private placement of warrants to purchase 147,500 shares at $8.00; exercisable for 5.5 years.
- H.C. Wainwright acted as sole placement agent; receives 7% cash fee and 10,325 warrants at $10.00.
- Net proceeds to be used for working capital and general corporate purposes.
- Closing occurred March 22, 2024; offering priced at-the-market under Nasdaq rules.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1733413/000121390024025167/0001213900-24-025167-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1733413/000121390024025167/ea0202366-8k_tffpharma.htm
  HTML page:      https://secwatch.observer/filing/0001213900-24-025167

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer